Statins impair glucose uptake in tumor cells

Shanmugasundaram Ganapathy-Kanniappan, Rani Kunjithapatham, Jean Francois H. Geschwind

Research output: Contribution to journalArticlepeer-review

Abstract

Statins play a pivotal role in lowering the blood cholesterol level, which is critical for patients with hypercholesterolemia. In addition to its benefits in cardiovascular protection, statins have been found to be useful in several other clinical conditions, including cancer. In a recent report that appeared in Neoplasia, Malenda et al., have demonstrated that statins inhibit glucose uptake in cancer cells. Using multiple statins and glucose analogs (18FDG and 6-NBDG) they showed that inhibition of cholesterol synthesis underlies the blockade of glucose uptake in several cancer cell lines. Further, based on an exploratory clinical study, they also showed that diagnostic PET-CT imaging in patients treated for hypercholesterolemia was affected due to statin-mediated inhibition of glucose uptake. As the finding is based on the data from a single patient (out of four), it seems that (1) the need for a large cohort study and (2) the detailed characterization of the molecular mechanisms underlying such biological effects would be justified.

Original languageEnglish (US)
Pages (from-to)92-94
Number of pages3
JournalCancer Biology and Therapy
Volume14
Issue number2
DOIs
StatePublished - Feb 2013

Keywords

  • Cancer
  • Cholesterol
  • FDG
  • GLUT1
  • Glucose uptake
  • PET imaging
  • Statins

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Statins impair glucose uptake in tumor cells'. Together they form a unique fingerprint.

Cite this